Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PGEN Precigen, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $7.81 +0.8% | $14.89 +0.2% |
| StockIQ Score | 58C Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 94A+ | 13F |
| Fundamental | 26F | 35F |
| Growth | 40D | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
PGEN outperforms AAPG in investor and technical scores, with 46 versus 37 and 57 versus 18, respectively. Both share the same valuation score of 38, but AAPG leads in growth at 50 compared to PGEN’s 40. Fundamentally, PGEN scores lower at 26, while AAPG sits at 35. PGEN’s overall rating is moderate, while AAPG is weak.
